Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Completed Phase 2 Trials for Erlotinib (DB00530)

Also known as: Stage IIIB Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090338 (Stage IIIB Non-Small Cell Lung Cancer AJCC v7)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00126581Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung CancerTreatment